Brivaracetam to Reduce Neuropathic Pain in Chronic Spinal Cord Injury

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
Spinal cord injury (SCI) is associated with severe neuropathic pain that is often refractory to all pharmacological intervention. Preliminary data suggest brivarecetum is a mechanism-based pharmacological intervention for neuropathic pain in SCI. This randomized, placebo-controlled pilot clinical trial will assess feasibility of a 3-month treatment course with brivarecetum.
Epistemonikos ID: 97fe977ff62be8e744336d3905a765e4fe81191b
First added on: May 07, 2024